Presentations & Publications

Presentation

Persistence of expanded TCRß clonotypes is associated with clinical activity of ADXS-PSA immunotherapy in metastatic castration-resistant prostate cancer

CRI-CIMT-EATI-AACR, September 9, 2017

STAY TUNED

Mailing List

Sign up for email alerts for Press Releases & breaking Advaxis news.

SOCIAL

Follow Us

Stay up to date on the latest events, news, and happenings on Advaxis and Immunotherapy.